These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

513 related articles for article (PubMed ID: 25801878)

  • 1. T cells as a therapeutic target in SLE.
    Comte D; Karampetsou MP; Tsokos GC
    Lupus; 2015 Apr; 24(4-5):351-63. PubMed ID: 25801878
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lupus and T cells.
    La Cava A
    Lupus; 2009 Mar; 18(3):196-201. PubMed ID: 19213856
    [TBL] [Abstract][Full Text] [Related]  

  • 3. T cell signaling abnormalities contribute to aberrant immune cell function and autoimmunity.
    Moulton VR; Tsokos GC
    J Clin Invest; 2015 Jun; 125(6):2220-7. PubMed ID: 25961450
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The critical role of epigenetics in systemic lupus erythematosus and autoimmunity.
    Long H; Yin H; Wang L; Gershwin ME; Lu Q
    J Autoimmun; 2016 Nov; 74():118-138. PubMed ID: 27396525
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tregs in SLE: an Update.
    La Cava A
    Curr Rheumatol Rep; 2018 Feb; 20(2):6. PubMed ID: 29464438
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Interleukin-2 signaling pathway regulating molecules in systemic lupus erythematosus].
    Guo Q; Chen XY; Su Y
    Beijing Da Xue Xue Bao Yi Xue Ban; 2016 Dec; 48(6):1100-1104. PubMed ID: 27987522
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interleukin-17 in systemic lupus erythematosus: A comprehensive review.
    Li D; Guo B; Wu H; Tan L; Chang C; Lu Q
    Autoimmunity; 2015; 48(6):353-61. PubMed ID: 25894789
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Altered regulation of IL-2 production in systemic lupus erythematosus: an evolving paradigm.
    Kammer GM
    J Clin Invest; 2005 Apr; 115(4):836-40. PubMed ID: 15841173
    [TBL] [Abstract][Full Text] [Related]  

  • 9. IL-23: a promising therapeutic target for systemic lupus erythematosus.
    Leng RX; Pan HF; Chen GM; Wang C; Qin WZ; Chen LL; Tao JH; Ye DQ
    Arch Med Res; 2010 Apr; 41(3):221-5. PubMed ID: 20682181
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of microRNA-31 as a novel regulator contributing to impaired interleukin-2 production in T cells from patients with systemic lupus erythematosus.
    Fan W; Liang D; Tang Y; Qu B; Cui H; Luo X; Huang X; Chen S; Higgs BW; Jallal B; Yao Y; Harley JB; Shen N
    Arthritis Rheum; 2012 Nov; 64(11):3715-25. PubMed ID: 22736314
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Abnormalities of T cell signaling in systemic lupus erythematosus.
    Moulton VR; Tsokos GC
    Arthritis Res Ther; 2011 Mar; 13(2):207. PubMed ID: 21457530
    [TBL] [Abstract][Full Text] [Related]  

  • 12. T-cell signaling abnormalities in human systemic lupus erythematosus.
    Nambiar MP; Krishnan S; Tsokos GC
    Methods Mol Med; 2004; 102():31-47. PubMed ID: 15286379
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interleukin 2 and systemic lupus erythematosus: beyond the transcriptional regulatory net abnormalities.
    Gómez-Martín D; Díaz-Zamudio M; Crispín JC; Alcocer-Varela J
    Autoimmun Rev; 2009 Sep; 9(1):34-9. PubMed ID: 19269352
    [TBL] [Abstract][Full Text] [Related]  

  • 14. New insights into the immunopathogenesis of systemic lupus erythematosus.
    Tsokos GC; Lo MS; Costa Reis P; Sullivan KE
    Nat Rev Rheumatol; 2016 Nov; 12(12):716-730. PubMed ID: 27872476
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The role of T cells in systemic lupus erythematosus: an update.
    Konya C; Paz Z; Tsokos GC
    Curr Opin Rheumatol; 2014 Sep; 26(5):493-501. PubMed ID: 25050923
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Decreased SAP Expression in T Cells from Patients with Systemic Lupus Erythematosus Contributes to Early Signaling Abnormalities and Reduced IL-2 Production.
    Karampetsou MP; Comte D; Kis-Toth K; Terhorst C; Kyttaris VC; Tsokos GC
    J Immunol; 2016 Jun; 196(12):4915-24. PubMed ID: 27183584
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Attempt to correct abnormal signal transduction in T lymphocytes from systemic lupus erythematosus patients.
    Fujii Y; Fujii K; Tanaka Y
    Autoimmun Rev; 2006 Feb; 5(2):143-4. PubMed ID: 16431347
    [TBL] [Abstract][Full Text] [Related]  

  • 18. T cell abnormalities in systemic lupus erythematosus.
    Takeuchi T; Tsuzaka K; Abe T; Yoshimoto K; Shiraishi K; Kameda H; Amano K
    Autoimmunity; 2005 Aug; 38(5):339-46. PubMed ID: 16227148
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differential expression of CD30 on CD3 T lymphocytes in patients with systemic lupus erythematosus.
    Cabrera CM; Urra JM; Carreño A; Zamorano J
    Scand J Immunol; 2013 Sep; 78(3):306-12. PubMed ID: 23790231
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Restoring regulation - IL-2 therapy in systemic lupus erythematosus.
    Humrich JY; Riemekasten G
    Expert Rev Clin Immunol; 2016 Nov; 12(11):1153-1160. PubMed ID: 27283871
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 26.